Ayupova, Guzel,
Litvinov, Sergey,
Akhmetova, Vita,
Minniakhmetov, Ildar,
Mokrysheva, Natalia,
Khusainova, Rita (2024) regulator gene (
CFTR)
mutations in the population, which is determined by genetic diversity and ethnicity
ПРОБЛЕМЫ И ДОСТИЖЕНИЯ В ИЗУЧЕНИИ КЛИНИКО-ГЕНЕТИЧЕСКИХ АСПЕКТОВ МУКОВИСЦИДОЗААЮПОВА, Г.Р.,
МИННИАХМЕТОВ, И.Р.,
ХУСАИНОВА, Р.И.,
AYUPOVA, G.R.,
MINNIAKHMETOV, I.R.,
KHUSAINOVA, R.I. (2022) синтеза, структуры и функции белка трансмембранного регулятора проводимости муковисцидоза (
CFTR - от англ
Клинико-генетическая характеристика муковисцидоза в Республике Башкортостан CFTR: Phe508del, E92K,
CFTRdele2,3, 3849+10kbC>T, L138ins, G509D, 394delTT, N1303K, W1282X, Y84X, 2143
Gilyazova, I.R.,
Yankina, M.A.,
Kunsbaeva, G.B.,
Klimentova, E.A.,
Izmaylov, A.A.,
V.N. Pavlov,
Khusnutdinova, E.K. (2016) patient. Bioinformatics analysis was conducted and the most significant
mutations in prostate cancer
Solovyev, A.V.,
Barashkov, N.A.,
Bady-Khoo, M.S.,
Zytsar, M.V.,
Posukh, O.L.,
Romanov, G.P.,
Rafailov, A.M.,
Sazonov, N.N.,
Alexeev, A.N.,
Dzhemileva, L.U.,
Khusnutdinova, E.K.,
Fedorova, S.A. (2017) The c.-23+1G>A splice site
mutation is one of the most frequent
mutations of gene GJB2 (Cx26, 13q11
Bai, Ming,
Wang, Xiaolong,
Zhang, Huixue,
Wang, Jianjian,
Lyaysan, Gaysina,
Xu, Si,
Tian, Kuo,
Wang, Tianfeng,
Li, Jie,
Wang, Na,
Lu, Xiaoyu,
Zhang, Xiaoming,
Wang, Lihua (2022) , we first performed an integrative framework to infer the clonal status of
mutations in glioblastomas
Akhmetgaleyevaa, A.F.,
Khidiyatovaa, I.M.,
Saifullinac, E.V.,
Idrisovad, R.F.,
Magzhanov, R.V.,
Khusnutdinovaa, E.K. (2016) in Europeans is HSP
associated with
mutations in the spastin gene (SPG4). Analysis of the gene SPG4 was carried
Nurgalieva, A.Kh.,
Petrova, Sabina G.,
Gallyamova, Lilia F.,
Ekomasova, Natalia V.,
Sakaeva, Dina D.,
Fedorova, Yulia Yu,
Dzhaubermezov, Murat A.,
Abdeev, Rustem R.,
Rakhimov, Radmir R.,
Khusnutdinova, Elza K.,
Prokofyeva, Darya S. (2025) of this study was to compare the prevalence of
mutations in the BRCA1 (c.68_69delAG, c.4035delA, c.5266dupC, c
Khidiyatova, I.M.,
Saifullina, E.V.,
Karunas, A.S.,
Akhmetgaleyeva, A.F.,
Kutlubaeva, R.F.,
Smakova, L.A.,
Lobov, S.L.,
Polyakov, A.V.,
Shchagina, O.A.,
Kadnikova, V.A.,
Ryzhkova, O.P.,
Magzhanov, R.V. (2022) predominant lesion of the pyramidal tract. The autosomal dominant form of SPG3A, associated with
mutations